Consumer Medicine Information (CMI) about Sacubitril/Valsartan Alphapharm intended for persons living in Australia.

Sacubitril/valsartan treatment is currently indicated in all symptomatic patients with heart failure with an ejection fraction ≤35% already treated with a β-blocker and an ACEi or ARB. 19 However, no ...

We evaluated the cost-effectiveness of sacubitril/valsartan (formerly LCZ696) compared with an ACE inhibitor (ACEI) (enalapril) in the treatment of HF-REF from the perspective of healthcare providers ...

BMI, or body mass index, is an outdated measurement that fails to properly identify health risks, according to a new study. Measuring body fat may be just as easy.